Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on the Influence of Calcium and Phosphorus Regulation Therapy on Valvular Heart Disease.

NCT06660524 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT06660524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06660524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on the Influence of Calcium and Phosphorus Regulation Therapy on Valvular Heart Disease.
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Phase 4
Overall status
Recruiting
Start date
March 1, 2024
Completion date
December 31, 2025
Enrollment
196 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

calcium-phosphorus metabolism disorders, chronic kidney disease(ckd), degenerative heart valve disease, heart valve calcification